aap Implantate

aap Implantate AG is a publicly traded, Berlin-based pure player in trauma surgery with a mission to make trauma treatment better and more cost-effective. The company has successfully commercialized its patented LOQTEQ® locking compression technology, building a comprehensive anatomical plate and screw system that covers over 95% of relevant indications in extremities. Its strategic focus is now on leveraging this foundation to develop and commercialize two high-potential, next-generation platform technologies: antibacterial silver-coated implants and resorbable magnesium implants, aiming to address the significant surgical challenges of infection and implant removal.

Patented LOQTEQ® locking compression technology enabling variable angle-stable fracture compression and secure screw-plate locking in a single step, serving as the foundation for advanced antibacterial silver-coating and resorbable magnesium implant platforms.

aap competes as a niche pure-play innovator against global giants like Johnson & Johnson (DePuy Synthes) and Stryker in the trauma market. Its strategy relies on technological differentiation in specific areas like cold-weld reduction, antibacterial coatings, and resorbable magnesium to carve out a market position.